Top Companies in Thailand Glaucoma Market | Competitive Landscape 2026

Thailand Glaucoma Market Overview

According to 6Wresearch, the Thailand glaucoma market is experiencing steady growth due to the increasing prevalence of glaucoma, rising awareness about eye health, and government initiatives supporting ophthalmic care. Innovations in drug therapies, minimally invasive surgical procedures, and better diagnostic technologies are further boosting the market growth. The use of glaucoma drugs, particularly prostaglandin analogs, beta-blockers, and combination treatments, along with the expansion of healthcare infrastructure, continues to propel market growth.

Competitive Landscape

The competitive landscape in the Thailand glaucoma market includes global pharmaceutical players and regional distributors. These companies contribute to the market diversity by offering a broad spectrum of products such as prescription drugs and advanced glaucoma surgical devices.

Leading Players Operating in the Thailand Glaucoma Market:

1. Novartis AG

A dominant leader in the Thai ophthalmic segment, Novartis provides a comprehensive portfolio of intraocular pressure (IOP) lowering medications, including the widely used Azarga and Simbrinza brands.

2. Santen Pharmaceutical Co., Ltd.

Santen is a specialized eye care global giant with a massive footprint in Thailand, renowned for leading the market with prostaglandin analogs like Tapros and its extensive range of preservative-free treatments.

3. Alcon Inc.

A major force in the surgical and pharmaceutical space, Alcon focuses on high-performance glaucoma drainage devices and advanced fixed-combination eye drops for complex patient needs.

4. AbbVie Inc.

Allergan remains a cornerstone of Thai glaucoma clinics, providing the XEN Gel Stent for surgical intervention and the Lumigan line of prostaglandin analogs.

5. Pfizer Inc.

A historic innovator in the field, Pfizer is responsible for Xalatan, the first prostaglandin analog that revolutionized glaucoma management and remains a standard of care in Thailand.

6. Siam Pharmaceutical Co., Ltd.

One of Thailand's leading local pharmaceutical companies, Siam Pharma specializes in providing high-quality, affordable generic glaucoma eye drops to ensure broad patient access.

7. Glaukos Corporation

A fast-growing pioneer in the premium MIGS segment, Glaukos provides the iStent technology, which is increasingly favored in Thailand for its safety and efficiency during cataract surgery.

8. Carl Zeiss Meditec AG

The global leader in diagnostic imaging, Zeiss provides the Humphrey Field Analyzer and OCT systems, which are the "Gold Standard" for glaucoma diagnosis in Thai hospitals.

9. Teva Pharmaceutical Industries Ltd.

Part of the global generic ecosystem, Teva focuses on providing affordable beta-blockers and carbonic anhydrase inhibitors that are vital for multi-drug glaucoma regimens.

10. Topcon Corporation

Provides high-precision automated tonometers and retinal imaging tools, supporting early detection initiatives in diverse industrial and rural settings across Thailand.